Tag: for

Document Requirements for EC Submission – Good Clinical Practice (GCP) and Compliance

July 8, 2025June 26, 2025

Document Requirements for EC Submission – Good Clinical Practice (GCP) and Compliance “Requirements for Submitting Documents to the EC” Introduction Submitting a clinical study to an Ethics Committee (EC) is a crucial step in the research process. This submission involves a set of documents that must adhere to the quality standards and guidelines set by…

Ethics Committee Roles, Good Clinical Practice (GCP) and Compliance

Risk Management and Quality Assurance for Sponsors – Good Clinical Practice (GCP) and Compliance

July 7, 2025June 26, 2025

digi

Risk Management and Quality Assurance for Sponsors – Good Clinical Practice (GCP) and Compliance “Sponsor’s Risk Management and Quality Assurance Procedures” Introduction In the clinical research industry, risk management and quality assurance are two pivotal aspects that ensure the integrity of the trial, the safety of the subjects, and the validity of the data collected….

Good Clinical Practice (GCP) and Compliance, Sponsor Responsibilities

Statistical Methods for Equivalence Testing – Clinical Trial Design and Protocol Development

June 24, 2025

digi

Statistical Methods for Equivalence Testing – Clinical Trial Design and Protocol Development “Quantitative Techniques for Equivalence Testing” Introduction to Statistical Methods for Equivalence Testing In the field of clinical research, one of the most crucial aspects to ensure the effectiveness of a new treatment or a drug is to conduct equivalence testing. This process involves…

Clinical Trial Design and Protocol Development, Non-Inferiority and Equivalence Trials

Regulatory Considerations for Blinded Trials – Clinical Trial Design and Protocol Development

June 23, 2025

digi

Regulatory Considerations for Blinded Trials – Clinical Trial Design and Protocol Development “Compliance Factors for Blind Trials” Introduction Blinded trials are an essential component of clinical research and are designed to reduce bias by preventing knowledge of treatment allocation from influencing the behavior of researchers, participants, and assessors. However, the execution of these trials requires…

Blinded Studies (Single, Double, Triple), Clinical Trial Design and Protocol Development

Endpoints Best Suited for Single-Arm Studies – Clinical Trial Design and Protocol Development

June 19, 2025

digi

Endpoints Best Suited for Single-Arm Studies – Clinical Trial Design and Protocol Development ‘Optimal Endpoints for Single-Arm Studies’ Introduction to Single-Arm Studies In the world of clinical research, single-arm studies have gained significant prominence as a reliable study design. Single-arm studies are typically observational studies where all participants receive the same intervention, without a comparison…

Clinical Trial Design and Protocol Development, Single-Arm Trials

Statistical Considerations for Single-Arm Studies – Clinical Trial Design and Protocol Development

June 17, 2025

digi

Statistical Considerations for Single-Arm Studies – Clinical Trial Design and Protocol Development “Analyzing Statistical Elements in Single-Arm Research Studies” Introduction to Single-Arm Studies Single-Arm studies are a type of clinical study where all participants receive the same investigational treatment. It is often used when it is considered unethical to withhold treatment from a control group,…

Clinical Trial Design and Protocol Development, Single-Arm Trials

Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development

June 12, 2025

digi

Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development “Rules and Regulations for Comparing Groups” Introduction Group comparisons in clinical studies are an essential aspect of pharmaceutical research and development. They enable researchers to measure the efficacy and safety of new drugs by comparing different groups of subjects. However, these comparisons must…

Clinical Trial Design and Protocol Development, Parallel Group Designs

Sample Size Calculation for Parallel Group Studies – Clinical Trial Design and Protocol Development

June 8, 2025

digi

Sample Size Calculation for Parallel Group Studies – Clinical Trial Design and Protocol Development “Calculating Sample Size for Parallel Group Research” Introduction to Sample Size Calculation for Parallel Group Studies Sample size calculation is a critical step in the planning of clinical trials, including parallel group studies. The sample size has a significant impact on…

Clinical Trial Design and Protocol Development, Parallel Group Designs

Operational Planning for Seamless Phase Transitions – Clinical Trial Design and Protocol Development

June 5, 2025

digi

Operational Planning for Seamless Phase Transitions – Clinical Trial Design and Protocol Development “Efficient Operational Planning for Smooth Phase Changes” Introduction to Operational Planning in Clinical Studies Operational planning for seamless phase transitions in clinical studies is a critical process that ensures the smooth progression of a clinical trial from one phase to another. This…

Adaptive Trial Designs, Clinical Trial Design and Protocol Development

Ethical Justification for Adaptive Modifications – Clinical Trial Design and Protocol Development

June 4, 2025

digi

Ethical Justification for Adaptive Modifications – Clinical Trial Design and Protocol Development “Moral Grounds for Adaptive Changes” Introduction In clinical research, adaptive modifications have become an increasingly significant tool. These modifications make a trial more flexible and efficient, potentially improving the delivered outcomes for patients. However, their implementation is not without ethical considerations. This article…

Adaptive Trial Designs, Clinical Trial Design and Protocol Development